Citarabina Accord

Cytarabine is a chemotherapy drug used to treat certain types of cancer, including leukemia. It works by slowing or stopping cancer cell growth. Learn more about cytarabine uses and effects.

Cytarabine is primarily used in the treatment of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). It may also be used for other types of cancer, depending on medical necessity. Cytarabine is often administered intravenously or subcutaneously, and its use is typically determined by a healthcare provider based on individual patient needs.

Common effects of cytarabine may include nausea, vomiting, and fatigue. Some patients may experience fever, mouth sores, or changes in blood cell counts. These effects can vary widely among individuals and should be discussed with a healthcare provider.

Cytarabine should be handled with care, as it is a potent chemotherapy agent. It is important to follow proper administration procedures to avoid contamination. Patients should be monitored for signs of infection or bleeding, as cytarabine can affect the bone marrow's ability to produce blood cells.

Cytarabine may interact with other medications, including those that suppress the immune system or affect blood cell production. It is important to inform healthcare providers about all medications being taken to avoid potential interactions. Alcohol and certain foods may also affect how cytarabine works in the body.